[email protected] | www.aidot.ai Cerviray AI protects women’s health from cervical cancer AI based cervical cancer remote read-out system Cerviray AI
[email protected] | www.aidot.ai
Cerviray AI protects women’s
health from cervical cancer
AI based cervical cancer remote read-out system
Cerviray AI
Cerviray AI
01
Auto focus
·
·
·
·
AI-Based Cervical cancer remote read-out system
Cerviray portable colposcope + AI Software
Pre-labled database from University Hospitals
(i.e Seoul National Univ., Korea Univ. Hospital)
Patented AI algorithm AidotNet v1.2
(Sensitivity 93%, Specificity 89%)+ AI software
02
Green filter
Convenient settingWireless transfer
Picture album
The most advanced portability and affordability
03 04
Portable colposcope spec.
Platform Spec Note
OSWindows VistaSP2 or laterAndroid 8.0 or later
Compatible with both PCs and tablets
.Net framework 4.0 or later
CPU Intel Dual core or higher
Memory 1GB or more
Storage 1GB or more
ResolutionPC version : Variable type Android Version : 1920 x 1200
AI Framework TensorFlow
AI Network AIDOTNet v1.2
Self - develope AI speciallzed for cervical cancerSensitivity : 93%Specificity : 89%
AI Software spec.
Technical Data
Display 5" 720*1280 IPS LCD + Touch Screen
Image Sensor1/2.8 8.29 Mega-pixelCMOS Image Sensor
Zoom Optical 3X ~ 5X
Focus Auto + Manual
F No F3.2 ~ F3.7
Effective image Circle diameter Φ5.92mm
Distance Sensor TOF
CPU Dual core ARM cortex-A7 CPU
RAM DDR3 2G RAM
The most advanced portability and affordability
05 06
All untrained HCP can screen the cervical dysplasia andcancer with remote consultation
ReportThe remote consultation
report can be sent
immediately
4
CervirayWeb Admin
· Sensitivity 93%
· Specificity 89%
· TTACertified Test Report
Server
A.I. initial diagnosis2
Normal
CIN 1
CIN 2,3
CIN 3+
Cervirayfor Experts
Remote consultationPhysicians can give the remoteconsultation
3
Picture1Image can taken by
any HCP at anywhere
Cerviray for Patients
Repeat the
Deep-LearningThe accuracy increase continuously
5
Cerviray Hand-held Colposcope
07 08
Micro SD card
Optical zoom lens
Shoot button
Battery
Wireless transfer
Green filter
Convenient setting
Auto focus
Picture album
Cerviray AI embedded
LCD touch screen
Power On/Off
Zoom / Focus
Cerviray AI Software
09 10
AIDOTNet v1.2 Structure
Input Layer(224*224)
Conv. #1(54*54)
Max.Pooling
Max.Pooling
Conv. #2(26*26)
DeConv. #3(12*12)
Conv. #3(12*12)
DeConv. #4(12*12)
Conv. #4(12*12)
Max.Pooling
DeConv. #6(4096)
DeConv. #7(4096)
DeConv. #7(4096)
DeConv. #5(12*12)
Conv. #5(12*12)
Add Layer(5*5)
DropOut
DropOut
Fully Convolution Network(FCN)
Output
+
Pre-labled database by university hospitals
ClinicalKnowledge
Apply
Database
KFDA Level 3
Normal
CIN 1
Sensitivity : Max 93%
Specificity : Max 89%
AidotNet v1.2 ; the patented algorithm for cervical cancer
KFDA level 3 (export)
Cerviray AI Software
11 12
Gorund Truth
(OB/GYN Dr.’s screening)
AI’s screening result
(Blind test)
On-site reading function
13 14
2.
1.
Select On-site Reading
5. Print report
Photographing the cervix
3. Refer to the initial AI result
Only 1 ~ 5 min.
4. Final Reading Handling
Remote reading function
15 16
2.
1.
Select Remote Reading
5. Print report
Photographing the cervix
3. Send patient informationand cervical images(request reading)
- Gynecology cacer gynecology oncologist
- Uterine Colposcopy Diagnostic Expert
- Assistant Professor of Obstetrics and Gynecology at Korea University Anam Hospital
- Full member of the Korean Society of Obstetrics and Gynecology
- Full member of the Korean Women’s Cancer Society
- Full member of the Korean Society of Obstetrics and Gynecology and Endoscopy
- Full member of the Korean Cancer Society
- Training member of the Korea Society for Oncology and Cancer
- Prevention Committee of the Korean Society for Gynecological Cancer
- An academic member of the Korean Society of Obstetrics and Gynecology.
- permanent member of the Korean Medical Laser Society
Song Jae-yun
(Professor of Korea UniversityAnam Hospital)
Director of the doctorgroup for reading
4. Show the results of thefirst reading by AI
Domestic or intercontinentalremote consultaion
Clinical Benefits
17 18
Faster and Higher accuracy, portability, affordability
Cytology VIA Colposcopy
Based on IFCPC(The International Federation ofCervical Pathology and Colposcopy) nomenclature
A day
Online remote reading
No Infra(visual inspection)
Accuracy 90%
Cytology
7 to 30 days
Read after sampledelivery
High Infra costs(laboratory)
false negative rate 55%
Cerviray AI
Clinical Benefits
19 20
Cerviray AI solution enables all Healthcare Professionals toimplement early screening without the barrier of training and cost
Importance of VIA and Cerviray AI’s solution to solve the problem
(Source: Cervical cancer screening and management of cervical pre-cancers, WHO, 2017)
HPV DNA test
� Scrubbing the uterine cervix cells
with a tool to collect a sample
� Samples are kept and sending to the lab
VIA
(Visual Inspection with Acetic acid,Colposcopy)
Visually observed after reacting 3~5%
acetic acid
Detect the lesion of dysplasia and cancer
by morphology
Cytology (Pap smear, LBC)
� Scrubbing the uterine cervix cells with a
tool to collect a sample
� Dedicated pathology resource can do
� Scrubbing process is simple
� Just send the sample to the Lab
� Need dedicated Lab resources
� High cost of Lab resource
� Diagnosis price is also high
� Difficulty in sample logistics
� Need long term training
Less than 1 min. for AI screening
Remote read-out by a doctor
� High price of equipment(Colposcope)
AI embedded in the super portable
colposcope (max. 1/10 lower price)
� Women are uncomfortable for the test
Remote read-out by a doctor
� Widely used in countries with good
medical care conditions
� Well known test method
� High false negative rate (up to 50%)
� Need dedicated resources
� High cost of resource
� Diagnosis price is also high
� Difficulty in sample logistics
� Simple inspection method
� Affordable
� Immediate result
� No infrastructure required
� Proven accuracy
� Can reduce unnecessary pathology
test and cost
Test Method Remark Problems and AIDOT’s solution
Clinical Benefits
07
Comparison Chart
08
Clinical Efficiency of Visual Inspection with Acetic acid
Clinical Benefits
21 22
(Source: Cervical cancer screening and management of cervical pre-cancers, WHO, 2017)
VIA and VILI are suitable for pre-screening tests for cervical cancer. Thanks to the
innovative technology, you can take a VIA-style cervical image continuously using a
smartphone.
Gallay C, Girardet A, Viviano M, et al. Cervical cancer screening in low-resource settings: a smartphone
image application as an alternative to colposcopy. Int J Womens Health. 2017;9:455‐461. Published2017 Jun 22. doi:10.2147/IJWH.S136351
VIA can be used alone or in combination with a cell test for screening tests forcervical cancer, and can also replace a cytoscopy if the medical environment ispoor.
DOI: 10.1200/JGO.17.00127 Journal of Global Oncology - published online February 28, 2018
The accuracy of the VIA is comparable to that of a cell test, and can replace the
cytoscopy.
Omole-Ohonsi A, Aiyedun T A, Umoru J U. Diagnostic accuracy of VIA compared to Pap smear cytologyin detecting premalignant lesions of the cervix. Afr J Med Health Sci 2013;12:25-30
VIA is more sensitive than cytoscopy and cell testing has higher specificity than VIA.
Therefore, VIA and cytoscopy are useful for complementary uses.
Basu, et al.(2003). Visual inspection with acetic acid and cytology in the early
detection of cervical neoplasia in Kolkata, India. International journal of gynecological cancer
: official journal of the International Gynecological Cancer Society. 13. 626-32. 10.1046/j.1525-1438.2003.13394.x.
Product name
Appearance
Cerviray
Korea
Portable / Optical / Digital
Auto + Manual
3X ~ 5X Optical
Battery driven
LED (anti-glare function)
Yes
Yes
Yes
Mobile ODT_EVA
Israel
Portable / Optical
Manual
4X optical
Battery driven
LED
Yes
No
No
Kejian-AD
China
Portable / Digital
Manual
Digital zoom to 12x
Battery driven
LED
Yes
No
No
MedGyn
U.S.
Portable / Digital
Manual
Digital zoom to 36x
Battery driven
LED
Yes
No
No
Leisegang Optik 2
Germany
Portable / Optical / Digital
Manual
3.75x, 7.5x, 15x
Cable power
LED
Yes
No
No
Country
Type
Focus
Opticalmagnification
Energy source
Lightsource
Greenfilter
Remotediagnosis
A.I.
References
23 24
j#Z'(,)%1'(#A%160-0:4# )'#)%.#(0
APA Waxman, et al. MD12 ASCCP Colposcopy Standards: How Do WePerform Colposcopy? Implications for Establishing Standards, Journal ofLower Genital Tract Disease: October 2017 - Volume 21 - Issue 4 - p 235-241https://journals.lww.com/jlgtd/FullText/2017/10000/ASCCP_Colposcopy_Standards__How_Do_We_Perform.5.aspx
Diagnosis of cervical precancer: Use of colposcopyhttps://obgynkey.com/diagnosis-of-cervical-precancer-use-of-colposcopy/
Gallay C, Girardet A, Viviano M, et al. Cervical cancer screening in lowresourcesettings: a smartphone image application as an alternative tocolposcopy. Int J Womens Health. 2017;9:455‐461. Published 2017 Jun 22.doi:10.2147/IJWH.S136351
Waxman AG, Buenconsejo-Lum LE, Cremer M, et al. Cervical CancerScreening in the United States-Affiliated Pacific Islands: Options andOpportunities. J Low Genit Tract Dis. 2016;20(1):97‐104. doi:10.1097
Sriplung H, et al. Success of a cervical cancer screening program: trends inincidence in songkhla, southern Thailand, 1989-2010, and prediction of futureincidences to 2030. Asian Pac J Cancer Prev. 2014;15(22):10003-8. PubMedPMID: 25520060.
1
2
3
4
5
6
SOGC/ SCC Clinical Practice Guideline : Colposcopic Management of AbnormalCervical Cancer Screening and Histologyhttp://ifcpc.org/newWP/wp-content/uploads/2017/10/Colposcopy-Guidelines-FINAL-2012-02-19.pdf
Mabeya H, Khozaim K, Liu T, et al. Comparison of conventional cervicalcytology versus visual inspection with acetic acid among humanimmunodeficiency virus-infected women in Western Kenya. J Low Genit TractDis. 2012;16(2):92‐97. doi:10.1097/LGT.0b013e3182320f0c
Walmer DK, Merisier D, Littman E, Rodriguez G, Venero N, Henderson M,Katz D, Edwards R. Portable colposcopy in low-resource settings. J AcquirImmune Defic Syndr. 2004 Oct;37 Suppl 3:S167-70. PubMed PMID: 16419267.
Jeanne S. Mandelblatt, et al. Costs and Benefits of Different Strategies toScreen for Cervical Cancer in Less-Developed Countries, JNCI: Journal of theNational Cancer Institute, Volume 94, Issue 19, 2 October 2002,Pages 1469–1483, https://doi.org/10.1093/jnci/94.19.1469
Basu PS, et al. Visual inspection with acetic acid and cytology in the earlydetection of cervical neoplasia in Kolkata, India. Int J Gynecol Cancer.2003 Sep-Oct;13(5):626-32. PubMed PMID: 14675346.
Shastri SS, Dinshaw K, Amin G, et al. Concurrent evaluation of visual,cytological and HPV testing as screening methods for the earlydetection of cervical neoplasia in Mumbai, India. Bull World Health Organ.2005;83(3):186‐194.
Egede J, Ajah L, Ibekwe P, Agwu U, Nwizu E, Iyare F. Comparison of theAccuracy of Papanicolaou Test Cytology, Visual Inspection WithAcetic Acid, and Visual Inspection With Lugol Iodine in Screening forCervical Neoplasia in Southeast Nigeria. J Glob Oncol. 2018 Sep;4:1-9. doi:10.1200/JGO.17.00127. PubMed PMID: 30241249; PubMed Central PMCID:PMC6223424.
Diagnostic accuracy of VIA compared to Pap smear cytology in detectingpremalignant lesions of the cervixOmole-Ohonsi A, Aiyedun T A, Umoru J U Year : 2013 | Volume: 12 | IssueNumber: 1 | Page: 25-30
8
9
10
11
12
13
7
25 26
Cerviray AI is used worldwide
to prevent cervical cancer
Contact us
[email protected] | www.aidot.ai